Promasys v6.0 has been formally released. There are some exiting new features implemented in this version. A new enlistment process is implemented which significantly reduces the number of steps required to put new subjects in a trial.

The subject ID generation algorithm has been extended to include study centre information as well as sequential numbering of subjects within a trial. This will allow you to implement a consistent assignment of subject IDs across the trial.

Version 6.0 allows you to connect directly to MedDRA and WHO-DD for coding of adverse events and concomitant medications. A flexible search tool is available which allows you to locate the preferred term you are looking for within a few seconds.

The new release also makes the eCRF module formally available to all customers. This form based data entry module will generate data entry screens based on the timetable flow implemented into the study design.

Getting to version 6.0 from your existing Promasys version is a simple and straightforward process. Moreover, the new release is provided at no additional cost to all customers who are on Maintenance and Support.

Now you can run your clinical trials and manage your data in compliance with international standards and regulations. Set up new trials without doing any programming. Improve the efficiency of your organization. And become more cost effective.

Promasys^® offers researchers and research organizations a tool for streamlining clinical trials. It provides the infrastructure for high-quality scientific research. The software architecture of Promasys, the extensive multi-center support and the detailed configurability of access rights make Promasys the ideal platform for clinical trial networks and multi-center studies. Click here to view the key features of Promasys.

Promasys has extensively proved its applicability in the field. Over a period of more than 20 years, the program has been developed and tested in a demanding clinical research environment. Promasys has demonstrated its strength in hundreds of clinical trials. To date, more than 300 trials managed in Promasys have resulted in publications in international scientific journals, with a growing number of (academic) hospitals and CROs using the software. Click on the following link to download the Promasys Introductory Presentation in PDF format.

PUMCH and Promasys visiting the Great Wall, May 2009

In 2009 Promasys BV is expanding its activities into one of the most important and exciting markets in the world: China. In May of this year the Peking Union Medical College Hospital (PUMCH) in Beijing was trained in using Promasys^® for their clinical research projects.

Peking Union Medical College Hospital is one of the biggest and oldest hospitals in China. It is a multi-functional hospital, active in the fields of medicine, education, and research. The Clinical Pharmacological Research Centre (CPRC) is attached to the PUMCH as the department of clinical pharmacology. The centre is well-known for its extensive experience in a variety of clinical trials on drugs of different developmental phases.

With the newly obtained governmental foundation, the CPRC decided to buy the Promasys system for its study management. Between May 11 and May 15, an on-site training was performed by Promasys BV at PUMCH. Most CPRC staff, including the director of phase I trial unit, attended the training. The training was evaluated as comprehensive and understandable. The interactions between the trainer and the trainees are thought to account for the fruitful outcome of this training. The CPRC team also gave great compliments to the benefits of Promasys software in terms of user friendliness, operational assistance, robust data-managing function.

Promasys BV is proud to cooperate with this prestigious hospital and wants to be present as a supplier of Clinical Trial and Data Management Systems in China.

Training for the Measles study WHO at the Christian

Medical Collegein Vellore, India, April 2009

Last year the World Health Organization (WHO) started to use Promasys^® software and was trained in its use in Bangkok, Thailand. In April 2009 we installed the updated Promasys version 5.1. Also a new training was given at the Thammasat University in Bangkok with participants from India, China and of course the Thai hosts themselves.

The cooperation of the WHO and Promasys BV is continued this year with the set up of the Measles Trial in Vellore, India. The WHO works in this project closely together with the Christian Medical College Hospital, the second largest hospital in India. This trial will include over 2000 subjects and will be managed with Promasys software.